المؤلفون: Khalil, Yara Abou, Rabès, Jean Pierre, Boileau, Cathérine, Varret, Mathilde

المساهمون: Laboratoire de Recherche Vasculaire Translationnelle (LVTS (UMR_S_1148 / U1148)), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris Cité (UPCité)-Université Sorbonne Paris Nord, Université Paris Cité (UPCité), Université Saint-Joseph de Beyrouth (USJ), Hôpital Ambroise Paré AP-HP, Université de Versailles Saint-Quentin-en-Yvelines - UFR Sciences de la santé Simone Veil (UVSQ Santé), Université de Versailles Saint-Quentin-en-Yvelines (UVSQ), 13CVD03 Agence Nationale de la Recherche, ANR: ANR-16-RHUS-0007 Fondation Leducq Institut National de la Santé et de la Recherche Médicale, Inserm Conseil National de la Recherche Scientifique, CNRS-L, YAK is supported by a grant from Ministère de l’Education Nationale et de la Technologie (France) , a grant from Nouvelle Société Francophone de l’Athérosclérose (France) , and a grant from Lebanese National Council for Scientifc Research (CNRS-L) ., This work was supported by grants from Leducq Foundation (FLQ # 13CVD03), The national project CHOPIN (CHolesterol Personalized Innovation) granted by the National Research Agency (ANR-16-RHUS-0007), INSERM (Institut National de la Sant? et de la Recherche M?dicale), Conseil de la recherche of Saint-Joseph University of Beirut, and CEDRE program.YAK is supported by a grant from Minist?re de l'Education Nationale et de la Technologie (France), a grant from Nouvelle Soci?t? Francophone de l'Ath?roscl?rose (France), and a grant from Lebanese National Council for Scientifc Research (CNRS-L)., This work was supported by grants from Leducq Foundation ( FLQ # 13CVD03 ), The national project CHOPIN (CHolesterol Personalized Innovation) granted by the National Research Agency ( ANR-16-RHUS-0007 ), INSERM (Institut National de la Santé et de la Recherche Médicale) , Conseil de la recherche of Saint-Joseph University of Beirut , and CEDRE program ., ANR-16-RHUS-0007,CHOPIN,CHOPIN(2016)

المصدر: ISSN: 0021-9150.

مصطلحات موضوعية: APOE, Autosomal dominant, Dysbetalipoproteinemia, Familial combined hyperlipidemia, Familial hypercholesterolemia, Genetic variants, Hypercholesterolemia, Lipoprotein glomerulopathy, [SDV]Life Sciences [q-bio]

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/34058468; hal-03288067; https://hal.science/hal-03288067Test; https://hal.science/hal-03288067/documentTest; https://hal.science/hal-03288067/file/PIIS002191502100232X.pdfTest; PUBMED: 34058468

الإتاحة: https://doi.org/10.1016/j.atherosclerosis.2021.05.007Test
https://hal.science/hal-03288067Test
https://hal.science/hal-03288067/documentTest
https://hal.science/hal-03288067/file/PIIS002191502100232X.pdfTest

المؤلفون: Mathilde Varret, Jean-Pierre Rabès, Catherine Boileau, Yara Abou Khalil

المساهمون: Laboratoire de Recherche Vasculaire Translationnelle (LVTS (UMR_S_1148 / U1148)), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris Cité (UPCité)-Université Sorbonne Paris Nord, Université Paris Cité (UPCité), Université Saint-Joseph de Beyrouth (USJ), Hôpital Ambroise Paré [AP-HP], Université de Versailles Saint-Quentin-en-Yvelines - UFR Sciences de la santé Simone Veil (UVSQ Santé), Université de Versailles Saint-Quentin-en-Yvelines (UVSQ), 13CVD03 Agence Nationale de la Recherche, ANR: ANR-16-RHUS-0007 Fondation Leducq Institut National de la Santé et de la Recherche Médicale, Inserm Conseil National de la Recherche Scientifique, CNRS-L, YAK is supported by a grant from Ministère de l’Education Nationale et de la Technologie (France) , a grant from Nouvelle Société Francophone de l’Athérosclérose (France) , and a grant from Lebanese National Council for Scientifc Research (CNRS-L) ., This work was supported by grants from Leducq Foundation (FLQ # 13CVD03), The national project CHOPIN (CHolesterol Personalized Innovation) granted by the National Research Agency (ANR-16-RHUS-0007), INSERM (Institut National de la Sant? et de la Recherche M?dicale), Conseil de la recherche of Saint-Joseph University of Beirut, and CEDRE program.YAK is supported by a grant from Minist?re de l'Education Nationale et de la Technologie (France), a grant from Nouvelle Soci?t? Francophone de l'Ath?roscl?rose (France), and a grant from Lebanese National Council for Scientifc Research (CNRS-L)., This work was supported by grants from Leducq Foundation ( FLQ # 13CVD03 ), The national project CHOPIN (CHolesterol Personalized Innovation) granted by the National Research Agency ( ANR-16-RHUS-0007 ), INSERM (Institut National de la Santé et de la Recherche Médicale) , Conseil de la recherche of Saint-Joseph University of Beirut , and CEDRE program ., ANR-16-RHUS-0007,CHOPIN,CHOPIN(2016), HAL UVSQ, Équipe, CHOPIN - - CHOPIN2016 - ANR-16-RHUS-0007 - RHUS - VALID, Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Paris (UP)-Université Sorbonne Paris Nord, Université de Paris (UP)

المصدر: Atherosclerosis
Atherosclerosis, 2021, 328, pp.11-22. ⟨10.1016/j.atherosclerosis.2021.05.007⟩
Atherosclerosis, Elsevier, 2021, 328, pp.11-22. ⟨10.1016/j.atherosclerosis.2021.05.007⟩

مصطلحات موضوعية: 0301 basic medicine, Apolipoprotein E, Candidate gene, Genetic variants, Apolipoprotein B, Familial dysbetalipoproteinemia, Familial combined hyperlipidemia, [SDV]Life Sciences [q-bio], Familial hypercholesterolemia, Hypercholesterolemia, Lipoprotein glomerulopathy, 030204 cardiovascular system & hematology, Hyperlipoproteinemia Type II, 03 medical and health sciences, 0302 clinical medicine, Apolipoproteins E, medicine, Humans, Dyslipidemias, Genetics, biology, PCSK9, medicine.disease, 3. Good health, [SDV] Life Sciences [q-bio], 030104 developmental biology, Autosomal dominant, Receptors, LDL, LDL receptor, biology.protein, lipids (amino acids, peptides, and proteins), Proprotein Convertase 9, Dysbetalipoproteinemia, Cardiology and Cardiovascular Medicine, APOE, Lipoprotein

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f25d7f89198ce6029941d2f327e21a68Test
https://hal.science/hal-03288067Test

المؤلفون: Kolovou, Genovefa D., Mikhailidis, Dimitri P., Kovar, Jan, Lairon, Denis, Nordestgaard, Borge G., Ooi, Teik Chye, Pérez-Martinez, Pablo, Bilianou, Helen, Anagnostopoulou, Katherine, Panotopoulos, George

المساهمون: Dept Cardiol, University of Ioannina, University College of London London (UCL), Institute for Clinical and Experimental Medicine (IKEM), Nutriments Lipidiques et Prévention des Maladies Métaboliques, Université de la Méditerranée - Aix-Marseille 2-Institut National de la Recherche Agronomique (INRA)-Institut National de la Santé et de la Recherche Médicale (INSERM), Université de la Méditerranée - Aix-Marseille 2, University of Copenhagen = Københavns Universitet (UCPH), University of Ottawa Ottawa, Universidad de Córdoba = University of Córdoba Córdoba, Hygeia Hosp, Partenaires INRAE, ASTRAZENECA SA HELLAS, ELAIS UNILIVER SA, ELPEN Pharmaceutical Company, Inc, GENZYME HELLAS LLC, SANOFI-AVENTIS, SCHERING-PLOUGH A.F.V.E.E., SOLVAY Pharma M.E.P.E.

المصدر: ISSN: 1570-1611 ; Current Vascular Pharmacology ; https://hal.inrae.fr/hal-02650073Test ; Current Vascular Pharmacology, 2011, 9 (3), pp.258 - 270.

مصطلحات موضوعية: Postprandial triglycerides, non-fasting triglycerides, chylomicron remnants, very low density lipoprotein remnants, cardiovascular disease, CORONARY-HEART-DISEASE, LOW-DENSITY-LIPOPROTEIN, PLASMA TRIACYLGLYCEROL CONCENTRATIONS, FAMILIAL COMBINED HYPERLIPIDEMIA, PROSPECTIVE CARDIOVASCULAR MUNSTER, CHYLOMICRON-REMNANT CLEARANCE, FACTOR INTERVENTION TRIAL, MIDDLE-AGED MEN, fat tolerance test, ESTER TRANSFER PROTEIN, METABOLIC SYNDROME, [SDV]Life Sciences [q-bio]

العلاقة: hal-02650073; https://hal.inrae.fr/hal-02650073Test; PRODINRA: 203687; WOS: 000290656600001

الإتاحة: https://hal.inrae.fr/hal-02650073Test

المؤلفون: Genovefa Kolovou, Jan Kovar, Børge G. Nordestgaard, Dimitri P. Mikhailidis, Katherine K. Anagnostopoulou, Helen Bilianou, Teik Chye Ooi, George Panotopoulos, Pablo Perez-Martinez, D. Lairon

المساهمون: Dept Cardiol, University of Ioannina, University College of London [London] (UCL), Institute for Clinical and Experimental Medicine (IKEM), Nutriments Lipidiques et Prévention des Maladies Métaboliques, Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut National de la Recherche Agronomique (INRA)-Université de la Méditerranée - Aix-Marseille 2, Université de la Méditerranée - Aix-Marseille 2, University of Copenhagen = Københavns Universitet (KU), University of Ottawa [Ottawa], Universidad de Córdoba [Cordoba], Hygeia Hosp, Partenaires INRAE, ASTRAZENECA SA HELLAS, ELAIS UNILIVER SA, ELPEN Pharmaceutical Company, Inc, GENZYME HELLAS LLC, SANOFI-AVENTIS, SCHERING-PLOUGH A.F.V.E.E., SOLVAY Pharma M.E.P.E., Université de la Méditerranée - Aix-Marseille 2-Institut National de la Recherche Agronomique (INRA)-Institut National de la Santé et de la Recherche Médicale (INSERM), University of Copenhagen = Københavns Universitet (UCPH), Universidad de Córdoba = University of Córdoba [Córdoba]

المصدر: Current Vascular Pharmacology
Current Vascular Pharmacology, Bentham Science Publishers, 2011, 9 (3), pp.258-270

مصطلحات موضوعية: PROSPECTIVE CARDIOVASCULAR MUNSTER, FAMILIAL COMBINED HYPERLIPIDEMIA, [SDV]Life Sciences [q-bio], 030204 cardiovascular system & hematology, 0302 clinical medicine, Risk Factors, cardiovascular disease, Hyperlipidemia, Hypolipidemic Agents, METABOLIC SYNDROME, Hypertriglyceridemia, Meal, Postprandial Period, 3. Good health, Postprandial, Cardiovascular Diseases, Cardiology and Cardiovascular Medicine, very low density lipoprotein remnants, medicine.medical_specialty, LOW-DENSITY-LIPOPROTEIN, 030209 endocrinology & metabolism, Context (language use), Hyperlipidemias, non-fasting triglycerides, fat tolerance test, CHYLOMICRON-REMNANT CLEARANCE, 03 medical and health sciences, ESTER TRANSFER PROTEIN, Chylomicron remnant, Internal medicine, medicine, Animals, Humans, CORONARY-HEART-DISEASE, MIDDLE-AGED MEN, Life Style, Triglycerides, FACTOR INTERVENTION TRIAL, 030203 arthritis & rheumatology, Pharmacology, business.industry, chylomicron remnants, Chylomicron remnant clearance, PLASMA TRIACYLGLYCEROL CONCENTRATIONS, medicine.disease, Dietary Fats, Endocrinology, Metabolic syndrome, business, Postprandial triglycerides

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8561411f9a4d904022246d4427256d73Test
https://hal.inrae.fr/hal-02650073Test